Scientists at the University of Texas in Dallas on 28 May 2013 designed a novel, small molecule that could help in the treatment of prostate cancer. The molecule’s effectiveness lies in blocking the cancer-promoting function of proteins called androgen receptors.
Androgen receptors are located inside cells. They have complex surfaces with several docking points where various proteins can bind to the receptor. Each docking point has got unique shape, so a molecule of correct shape will fit. Androgen hormones, such as testosterone are described as the primary molecules that bind to androgen receptors.
Such binding triggers a series of events that activates various processes in the human body. It also stimulates the development and maintenance of male characteristics.